Rejected at 5:11 a.m. Jan, 16, 2025 ] by mohannadkh10
Author: jhold33
Related Note: 1485913611683 1
Rationale for change

I think this mneumonic for odds is better than the previous one because both control and cohort have O's in them so it can get confusing
Source: Other - mneumonic

Rejection reason

Comments

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#FirstAid::06_Public_Health::01_Epidemiology_and_Biostatistics::01_Observational_studies::*Case-Control_Study #AK_Step1_v12::^Systems::Biostats #AK_Step1_v12::#Physeo::04_Biostatistics::01_Biostatistics::09_Measurements_of_Risk #AK_Step2_v12::#Resources_by_rotation::biostats::dorian::study_designs #AK_Other::AnKing_Image::Mujeeb::Difference_between_studies_by_time #AK_Step1_v12::#SketchyBiostats/Epidemiology::01_Biostatistics::01_Biostatistics_&_Data::08_Odds_Ratio_&_Hazard_Ratio #AK_Step2_v12::#B&B::05_Epidemiology::01_General::06_Risk_Quantification::Extra #AK_Other::AnKing_Image::!Subjects::Epidemiology_&_Social_Sciences::Study_Designs #AK_Step2_v12::#UWorld::Step::20274 #AK_Step1_v12::#UWorld::Step::1277 #AK_Step1_v12::#B&B::05_Biostats/Epi::02_Epidemiology::01_Study_Designs #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#B&B::05_Biostats/Epi::02_Epidemiology::02_Risk_Quantification::Extra #AK_Step2_v12::#FirstAid::04_Epidemiology::04_Measures_of_Effect::01_Measures_of_Effect::Extra #AK_Step1_v12::#SketchyBiostats/Epidemiology::02_Epidemiology::01_Study_Designs::04_Case-Control_Studies #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#UWorld::Step::20466 #AK_Step3_v12::#UWorld::9945 #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#UWorld::COMLEX::24388 #AK_Step2_v12::#NBME::Form10 #AK_Other::AnKing_Image::!Subjects::Epidemiology_&_Social_Sciences::Difference_between_studies_by_time #AK_Step2_v12::#FirstAid::04_Epidemiology::05_Types_of_Clinical_Studies::05_Randomized_Controlled_Trial #AK_Step1_v12::#Bootcamp::Biostatistics::03_Risk_Quantification::07_Odds_Ratio_And_Relative_Risk_Practice_Question_1 #AK_Step2_v12::#UWorld::Step::20754 #AK_Step1_v12::#Bootcamp::Biostatistics::01_Research_Study_Designs::03_Longitudinal_Studies #AK_Step2_v12::#UWorld::COMLEX::104662 #AK_Step2_v12::#B&B::05_Epidemiology::01_General::05_Study_Designs #AK_Step2_v12::#UWorld::Step::20283 #AK_Step2_v12::#NBME::Form11::Section_2 #AK_Step2_v12::Original_decks::Zanki_Step_2::Biostats::Step_1_Biostats #AK_Step2_v12::#UWorld::COMLEX::104759 #AK_Step1_v12::#Bootcamp::Biostatistics::03_Risk_Quantification::06_Odds_Ratio #AK_Step2_v12::#FirstAid::04_Epidemiology::05_Types_of_Clinical_Studies::04_Case-Control_Study::Extra #AK_Step1_v12::#UWorld::Step::19619 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#AMBOSS::t3aX44 #AK_Step2_v12::#AMBOSS::-E0Dy3 #AK_Other::Table::Study_Types #AK_Step2_v12::Original_decks::Dorian::im::biostats::study_designs #AK_Other::AnKing_Image::Mujeeb #AK_Step1_v12::#Physeo::04_Biostatistics::01_Biostatistics::02_Study_Designs #AK_Step2_v12::#AMBOSS::t3aX44 #AK_Step2_v12::#Resources_by_rotation::biostats::zanki::step1_biostats #AK_Step3_v12::#UWorld::105577 #AK_Step1_v12::#UWorld::COMLEX::27146 #AK_Step1_v12::#NBME::21 #AK_Step2_v12::#Subjects::Epidemiology_&_Social_Sciences::Biostats::Study_Types #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Public_Health_Sciences::Epidemiology_&_Biostats #AK_Other::AnKing_Image::Mujeeb::Study_Designs #AK_Step2_v12::#UWorld::COMLEX::104655